Navigation Links
CardioGenics Holdings Inc. Announces Name, Ticker Symbol and CUSIP Number Change
Date:10/26/2009

MISSISSAUGA, Ontario, Oct. 26 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: JAGH) has received notification from FINRA that the name and ticker symbol change for the Company on the OTCBB will take place at the beginning of business on Tuesday, October 27, 2009. The new ticker symbol for "CardioGenics Holdings Inc." on the OTC Bulletin Board will be "CGNH". In addition to the name and ticker symbol change that is scheduled to take place tomorrow on the OTC Bulletin Board, the CUSIP for the Company's common stock will also change tomorrow to 14160X 104. For reference of the official change, please visit the following link: http://www.otcbb.com/asp/dailylist_detail.asp?mkt_ctg=OTCBB&d=10/26/2009.

About CardioGenics Holdings Inc.

Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

SOURCE CardioGenics Holdings Inc.


'/>"/>
SOURCE CardioGenics Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc.
2. JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc.
3. JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc.
4. JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.
5. JAG Media Holdings, Inc. Amends Articles of Incorporation
6. Select Medical Holdings Corporation Successfully Completes Initial Public Offering of Common Stock
7. CMHS (dba Hybrid Energy Holdings) changes name of corporation and prepares to file for ticker symbol change with FINRA
8. Pacific Shore Holdings, Inc. Begins Clinical Trial With Burner Balm
9. JAG Media Holdings, Inc. Announces Agreement with The Investor Relations Group, Inc.
10. Select Medical Holdings Corporation Commences Initial Public Offering of Common Stock
11. HMS Holdings Corp. to Present at Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...vidence of a statistically significant survival be... estrogen receptor (ER)-positive tumors had high l...8 (ER-alpha S118-P), according to a brief communic... of the National Cancer Institute . , Approximat...xifen. Preclinical studies have shown that ER-alph...
(Date:11/25/2009)... fight rheumatoid arthritis, could help newly diag...AY, Nov. 25 (HealthDay News) -- A drug commonly us...arthritis now also shows some promise in helping p... The drug, rituximab (Rituxan), helped patients ke...h the disease had destroyed some of their pancreat...
(Date:11/25/2009)... sees few signs of trouble with the H1N1 vaccine,... -- The ongoing H1N1 swine flu pandemic may be dri...younger patients, a U.S. health official said Wedn...pneumococcal infections around the country," Dr. A...Immunization and Respiratory Diseases at the U.S. ...
(Date:11/25/2009)...ncer vaccine carried into the body on a carefully ...to successfully eliminate tumors in mammals, scien...nslational Medicine . , The new approach, pionee...niversity, uses plastic disks impregnated with tum...to reprogram the mammalian immune system to attack...
(Date:11/25/2009)...n flesh that mimicked parts of speech colored perc...(HealthDay News) -- People can "hear" not only wit...ch shows. , In fact, sensations on the skin des...lped people decipher sounds better, the Canadian s...show whether we could use tactile information in t...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...r Martin Watterson and team from Northwestern Univ...ew compound called MW01-5-188WH which has been fou... Cytokines which leads to activation of glia, whic...lzheimer’s disease is characterized by loss in mem...
...ria parasites can develop in the lymph nodes also,...ard. This reportedly has implications for the mamm...se is caused when a mosquito infected with Plasmod...s and infect red blood cells, beginning the onset ...
...published in the Journal of Infectious Diseases ha...f Staphylococcus aureus in nasal samples, // among...ive factor in a majority of the hospital acquired ...n the US. About 1% of the nasal samples test...
...r Rosemary Crompton conducted a survey in 5 Europe...ween work life and domestic life // to find out w... would like to have a traditional life style, the ... Researchers found that women who worked hard...
...n who underwent the world’s first face transplant ...hospital. Doctors say that she is increasing the r... Isabelle Dinoire, 38, hailing from France was...e donor of the face was a 46-year old teacher who ...
...k antibiotic drug which is used for treating lung ... failure, according to a report. //Medical practit...aid that they found three cases of liver failure i...f each other last year, said report co-author John...
Other Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2Health News:90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose 2
(Date:11/25/2009)...PARK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTe...efoamthatstopsseverebleeding,wonfirstprizeand$10,0...lSecurityChallenge2009,companyofficialsannouncetod...theworld,Remedium,steampitchedtheirinventionattheG...usiness. ,, Remedium( www.remediumtechnologies....
(Date:11/25/2009)...China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyO...)(Nasdaq: CSKI ),a,leadingfullyintegratedpharmaceu...rdrugsinthePeople,sRepublicofChina("PRC"),today,an...nalInstitutefor,theControlofPharmaceuticalandBiolo...oducts:itsDiagnosticKitforHumanProstateSpecific,An...
(Date:11/25/2009)...TY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc...ingpoint-of-carebloodanalysissystems,announcedtoda...r,willpresentatthe21stAnnualPiperJaffrayHealthCare...heconferencewillbeheldattheNewYorkPalaceHotelinNew...,manufacturesandmarketsportablebloodanalysissystem...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Treating Workers Mental Woes May Boost Productivity 56746 1Treating Workers Mental Woes May Boost Productivity 56746 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 1Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4
... GlaxoSmithKline (NYSE: GSK ),announced positive...d placebo-,controlled ITP Study with Eltrombopag),... adults with chronic immune (idiopathic) thrombocy... prior ITP therapies. Patients,receiving PROMACTA ... to,maintain platelet counts between 50,000 to 400...
...Bayer HealthCare Pharmaceuticals Inc. announced to...ine(R) (sargramostim) will be presented at the 50t...logy (ASH) from December 6-9, 2008 in San Francisc...m leading oncology and hematology research centers... presentations reporting important findings in leu...
Other Medicine Technology:GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 2GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 3GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 4GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 6GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 7GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 8Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 2Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 3Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 4Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 5Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 6
Liquichek Urinalysis Control
qUAntify Plus Control
Lyphochek Fertility Control
Liquichek Spinal Fluid Control
Medicine Products: